Hypertension, magnesium deficiency and an increased carotid intima media thickness

Trace Elements and Electrolytes

Volumn 25, Issue 1, 2008, Pages 41-44

  Kisters, K ^a,c   Al Tayer, H ^a   Liebscher, H ^b   Cziborra, M ^a   Wessels, F ^a   Buntzel J ^c   Nguyen, M Q ^a   Micke, O ^c   Tokmak, F ^c   Gremmler, B ^d   Hausberg, M ^c  

^a ST ANNA HOSPITAL   (Germany)

^b SHO Mineralimbalancen eV   (Germany)

^c AKTE   (Germany)

^d Department of Cardiology ^*  (Germany)

Author keywords

Carotids; Intima media thickness; Magnesium; Primary hypertension

Indexed keywords

MAGNESIUM;

ADULT; ARTERIOSCLEROSIS; ARTICLE; CAROTID ARTERY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; INTIMA; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THICKNESS; WORLD HEALTH ORGANIZATION;

EID: 38549162365     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ++ deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science. 1983; 221: 376-378.
2. ++ in excitable cells: its measurement and its biologic significance. Can J Physiol Pharmacol. 1987; 65: 915-925.
3. Asmar R. Long-term effects of converting enzyme inhibitors, calcium antagonist and β-blocking agents on peripheral and central arteries. In: Safar ME, O'Rourke MF (eds). Arterial stiffness in hypertension, Volume 23. Elsevier; 2006
4. Atkinson J. Elastin, calcium and the arterial wall. In: Safar ME, O'Rourke MF (eds). Arterial stiffness in hypertension, Volume 23. Elsevier; 2006.
5. Bots ML, Hoes AW, Koudstaal PJ, Hofmann A, Grobbee DE. Common caroted intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997; 96: 1432-1437.
6. Boutouyrie P, AI Tropeano R, Asmar I, Gautier A, Bentos P, Lacolley W, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002; 39: 10-15.
7. Dijk JM, Bots ML. Carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk and modifications by treatment. In: Safar ME, O'Rourke MF (eds). Arterial stiffness in hypertension, Volume 23. Elsevier; 2006a.
8. Dijk JM, van der Graaf Y, Michiel M, Bots ML, Gobbee DE, Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: The SMART study. European Heart Jounal. 2006b; 27: 1971-1978.
9. Durlach J. Magnesium in clinical practice. London: John Libbey; 1988. p. 360.
10. Durlach J, Durlach V, Rayssiguier Y, Bara M, Guiet-Bara A. Magnesium and blood pressure. II. Clinical studies. Magnes Res. 1992; 5: 147-153.
11. Goldstein S, Zsoter TT. The effect of magnesium on the response of smooth muscle to 5-hydroxytryptamine. Br J Pharmacol. 1978; 62: 507-514.
12. Hodis HN, Mack WJ, LaBree L et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998; 128: 262-269.
13. Kisters K, Spieker C, Tepel M, Zidek W. New data about effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res. 1993; 4: 355-360.
14. ++ concentrations in a subgroup of hypertensives - cell models for the pathogenesis of primary hypertension. J Hum Hypertens. 1997; 11: 367-372.
15. Kisters K, Tepel M, Spieker C, Zidek W, Barenbrock M, Tokmak F, Kosch M, Hausberg M, Rahn KH. Decreased cellular Mg++ concentrations in a subgroup of hypertensives. Am J Hypertens. 1998a; 11: 1390-1393.
16. + exchange in vascular smooth muscle cells from SHR. Clin Sci. 1998b; 95: 583-587.
17. Kisters K, Barenbrock M, Louwen F, Hausberg M, Rahn KH, Kosch M. Membrane, intracellular and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens. 2000a; 13: 765-769.
18. Kisters K, Krefting ER, Hausberg M, Kohnert K, Honig A, Bettin D. Importance of decreased intracellular phosphate and magnesium concentrations and reduced ATPase activities in SHR. Magnes Res. 2000b; 13: 183-188.
19. Kisters K, Hausberg M, Kosch M. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxy-corticosterone acetate-induced hypertenstion in rats. J Hypertens. 2001; 1: 161-162.
20. Kisters K, Wessels F, Tokmak F, Küper H, Hausberg M, Krefting ER. Increased arterial smooth muscle cell calcium and decreased magnesium concentrations in spontaneously hypertensive rats (SHR) and in human hypertension. Trace Elem Electrolytes. 2003; 21: 201.
21. Kisters K, Wessels F, Tokmak F, Krefting ER, Gremmler B, Kosch M, Hausberg M. Early-onset increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in SHR versus WKY. Magnes Res. 2004a; 17: 264-269.
22. Kisters K, Wessels F, Küper H, Tokmak F, Krefting ER, Gremmler B, Kosch M, Barenbrock M, Hausberg M. Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in spontaneously hypertensive rats versus Wistar-Kyoto rats. Am J Hypertens. 2004b; 17: 59-62.
23. Kisters K, Tokmak F, Gremmler B, Kosch M, Hausberg M. Increased calcium/magnesium ratio in young and old SHR - pathogenetic factor in the development of hypertension and vascular fibrosis. Am J Hypertens. 2005a; 18: 1136.
24. Kisters K, Gremmler B, Hausberg M. Magnesium and arterial stiffness. Hypertension (Epub) Dec. 2005b.
25. Kisters K, Hoffmann O, Hausberg M, Funke C, Kozianka J, Gremmler B. Magnesium und Pulsdruck bei Hypertonie. Nieren- und Hochdruckkrh. 2005c; 10: 455-457.
26. Kisters K, Gremmler B, Hausberg M. Pulse pressure, plasma magnesium status, and antihypertensive therapy. Am J Hypertens. 2005d; 18: 1136.
27. Kisters K, Hoffmann O, Gremmler B, Hausberg M. Plasma magnesium defiency ist correlated to pulse pressure values in essential hypertension - influence of a metabolic syndrome. Am J Hypertens. 2005e; 18: 215A.
28. Kisters K, Wessels F, Gremmler B, Quang Nguyen M, Kosch M, Hausberg M. Early onset of decreased intracellular magnesium and phosphate concentration in smooth muscle cells auf SHR. Am J Hypertens. 2005f; 23: 233.
29. Kisters K, Hoffmann O, Hausberg M, Quang Nguyen M, Micke O, Gremmler B. Plasma magnesium status and pulse pressure in essential hypertension. Trace Elem Electrolyt. 2005g; 22: 254-256.
30. Kisters K, Wessels F, Krefting ER, Gremmler B, Quang Nguyen M, Kozianka J, Hausberg M. Early onset of a decreased intracellular magnesium and phosphate concentration in smooth muscle cells of SHR. Magnes Res. 2005h; 18: 207-213.
31. Kisters K, Gremmler B, Hausberg M. Preventing pregnancy-induced hypertension: the role of calcium and magnesium. J Hypertens. 2006a; 24: 2010.
32. Kisters K, Gremmler B, Kozianka J, Hausberg M. Magnesium deficiency and diabetes mellitus. Clinical Nephrology. 2006b; 65: 77-78.
33. Laurent S, Katsahian S, Fassot C. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34: 1203-1206.
34. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension. 2005; 45: 1050-1055.
35. O'Rourke MF, Franklin SS. Arterial stiffness: reflections on the arterial pulse. European Heart Journal. 2006; 27: 2497-2498.
36. ++ in the arterial wall. J Physiol (Lond). 1971; 218: 353-368.
37. Rayssiguier Y, Mbega HD, Durchlach V, Gueux E, Durlach J, Giry J, Dalle M, Mazur A, Laurant P, Berthelot A. Magnesium and blood pressure. I. Animal studies. Magnes Res. 1992; 5: 139-146.
38. Resnick LM, Laragh JH, Sealey JE, Aldermann MH. Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983; 309: 888-891.
39. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acta Sc USA. 1984; 81: 6511-6515.
40. Rock E, Astier C, Lab C, Maluech C, Nowacki W, Gueux E, Mazur A, Rayssiguier Y. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnesium Res. 1995; 8: 237-242.
41. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991; 11: 1245-1249.
42. Staessen JA, Li Y, Thijs L, Wang JG. Antihypertensive drug treatment and cardiovascular prevention: an update including the 2003 - 2004 secondary prevention trials. In: Safar ME, O'Rourke MF (eds). Arterial stiffness in hypertension, Volume 23. Elsevier; 2006.
43. Touyz RM, Milne FJ. Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. Am J Hypertens. 1999; 12: 757-765.
44. ++ uptake channels. TRPM6 and TRPM7 in vascular smooth muscle cells from WKY and SHR differential regulation bei aldosterone and angiotensin II. Am J Hypertens. 2004; 5: 176.
45. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet. 2003; 362: 1527-1535.
46. ++ on calcium current in isolated cardiac myocytes. Sci ence. 1988; 239: 778-780.
47. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomised, double-blind, long-term trial. Circulation. 2002; 106: 2422-2427.
48. Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Tizzoni D, Payeras AC, Hamm C, McVeig G. Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 systems: Reliability, repeatability, and establishment of normal values for healthy European population - the Seven European Sites Study (SESS). Am J Hypertens. 2005; 18: 65-71.